National Institute of Diabetes And Digestive and Kidney Diseases; Notice of Meetings, 73302 [2021-28000]
Download as PDF
<![CDATA[
73302
Federal Register / Vol. 86, No. 245 / Monday, December 27, 2021 / Notices
biologic products is approved under
OMB control number 0910–0014.
III. Electronic Access
Persons with access to the internet
may obtain the guidance at either
https://www.fda.gov/drugs/guidancecompliance-regulatory-information/
guidances-drugs, https://www.fda.gov/
vaccines-blood-biologics/guidancecompliance-regulatory-informationbiologics/biologics-guidances, https://
www.fda.gov/regulatory-information/
search-fda-guidance-documents, or
https://www.regulations.gov.
Dated: December 21, 2021.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2021–28051 Filed 12–23–21; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes And
Digestive and Kidney Diseases; Notice
of Meetings
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
Date: May 11–12, 2022.
Open: May 11, 2022, 10:00 a.m. to 1:30
p.m.
Agenda: To present the Director’s Report
and other scientific presentations.
Place: National Institutes of Health
Building 31, C-Wing 6th Floor Conference
VerDate Sep<11>2014
19:11 Dec 23, 2021
Jkt 256001
Center, Conference Rooms C, D&E, and F&G,
31 Center Drive, Bethesda, MD 20892.
Closed: May 12, 2022, 1:30 p.m. to 2:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
Building 31, C-Wing 6th Floor Conference
Center, Conference Rooms C, D&E, and F&G,
31 Center Drive, Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D.,
Director Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council Diabetes, Endocrinology and
Metabolic Diseases Subcommittee.
Date: May 11–12, 2022.
Open: May 12, 2022, 10:00 a.m. to 11:30
a.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health
Building 31, C-Wing 6th Floor Conference
Center, Conference Rooms C, D&E, and F&G,
31 Center Drive Bethesda, MD 20892.
Closed: May 12, 2022, 11:45 a.m. to 1:15
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
Building 31 Conference Rooms C, D&E, and
F&G 31 Center Drive Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D.,
Director Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council Digestive Diseases and Nutrition
Subcommittee.
Date: May 11–12, 2022.
Open: May 12, 2022, 10:00 a.m. to 11:30
a.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health
Building 31, C-Wing 6th Floor Conference
Center, Conference Rooms C, D&E, and F&G,
31 Center Drive Bethesda, MD 20892.
Closed: May 12, 2022, 11:45 a.m. to 1:15
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
Building 31 Conference Rooms C, D&E, and
F&G 31 Center Drive Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D.,
Director Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council Kidney, Urologic and Hematologic
Diseases Subcommittee.
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
Date: May 11–12, 2022.
Open: May 12, 2022, 10:00 a.m. to 12:00
p.m.
Agenda: To review the Division’s scientific
and planning activities.
Place: National Institutes of Health
Building 31, C-Wing 6th Floor Conference
Center, Conference Rooms C, D&E, and F&G,
31 Center Drive Bethesda, MD 20892.
Closed: May 12, 2022, 12:15 p.m. to 1:15
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
Building 31, C-Wing 6th Floor Conference
Center, Conference Rooms C, D&E, and F&G,
31 Center Drive Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D.,
Director Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy
Boulevard, Room 7329, MSC 5452, Bethesda,
MD 20892, (301) 594–4757, malikk@
niddk.nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for
entrance onto the NIH campus. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors will be asked to show
one form of identification (for example,
a government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page:
www.niddk.nih.gov/fund/divisions/
DEA/Council/coundesc.htm, where an
agenda and any additional information
for the meeting will be posted when
available.
(Catalogue of Federal Domestic
Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic
Research; 93.848, Digestive Diseases and
Nutrition Research; 93.849, Kidney
Diseases, Urology and Hematology
Research, National Institutes of Health,
HHS).
Dated: December 20, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–28000 Filed 12–23–21; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\27DEN1.SGM
27DEN1
]]>Agencies
[Federal Register Volume 86, Number 245 (Monday, December 27, 2021)]
[Notices]
[Page 73302]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28000]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes And Digestive and Kidney Diseases;
Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of meetings of the National Diabetes
and Digestive and Kidney Diseases Advisory Council.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council.
Date: May 11-12, 2022.
Open: May 11, 2022, 10:00 a.m. to 1:30 p.m.
Agenda: To present the Director's Report and other scientific
presentations.
Place: National Institutes of Health Building 31, C-Wing 6th
Floor Conference Center, Conference Rooms C, D&E, and F&G, 31 Center
Drive, Bethesda, MD 20892.
Closed: May 12, 2022, 1:30 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health Building 31, C-Wing 6th
Floor Conference Center, Conference Rooms C, D&E, and F&G, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D., Director Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594-4757, [email protected].
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council Diabetes, Endocrinology and Metabolic
Diseases Subcommittee.
Date: May 11-12, 2022.
Open: May 12, 2022, 10:00 a.m. to 11:30 a.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health Building 31, C-Wing 6th
Floor Conference Center, Conference Rooms C, D&E, and F&G, 31 Center
Drive Bethesda, MD 20892.
Closed: May 12, 2022, 11:45 a.m. to 1:15 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health Building 31 Conference
Rooms C, D&E, and F&G 31 Center Drive Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D., Director Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594-4757, [email protected].
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council Digestive Diseases and Nutrition
Subcommittee.
Date: May 11-12, 2022.
Open: May 12, 2022, 10:00 a.m. to 11:30 a.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health Building 31, C-Wing 6th
Floor Conference Center, Conference Rooms C, D&E, and F&G, 31 Center
Drive Bethesda, MD 20892.
Closed: May 12, 2022, 11:45 a.m. to 1:15 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health Building 31 Conference
Rooms C, D&E, and F&G 31 Center Drive Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D., Director Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594-4757, [email protected].
Name of Committee: National Diabetes and Digestive and Kidney
Diseases Advisory Council Kidney, Urologic and Hematologic Diseases
Subcommittee.
Date: May 11-12, 2022.
Open: May 12, 2022, 10:00 a.m. to 12:00 p.m.
Agenda: To review the Division's scientific and planning
activities.
Place: National Institutes of Health Building 31, C-Wing 6th
Floor Conference Center, Conference Rooms C, D&E, and F&G, 31 Center
Drive Bethesda, MD 20892.
Closed: May 12, 2022, 12:15 p.m. to 1:15 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health Building 31, C-Wing 6th
Floor Conference Center, Conference Rooms C, D&E, and F&G, 31 Center
Drive Bethesda, MD 20892.
Contact Person: Karl F. Malik, Ph.D., Director Division of
Extramural Activities, National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452,
Bethesda, MD 20892, (301) 594-4757, [email protected].
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one form
of identification (for example, a government-issued photo ID, driver's
license, or passport) and to state the purpose of their visit.
Information is also available on the Institute's/Center's home
page: www.niddk.nih.gov/fund/divisions/DEA/Council/coundesc.htm, where
an agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and
Hematology Research, National Institutes of Health, HHS).
Dated: December 20, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-28000 Filed 12-23-21; 8:45 am]
BILLING CODE 4140-01-P
